Regeneron Reports Q4 Earnings Beat, Revenue Meets Estimates
TARRYTOWN, N.Y., United States (AP) - Regeneron Pharmaceuticals Inc. (REGN) announced fourth-quarter net income of $917.7 million on Tuesday. On a per-share basis, the Tarrytown, New York-based company reported earnings of $8.06. Adjusted for stock option expense and non-recurring costs, earnings reached $12.07 per share, surpassing Wall Street estimates.
Analysts surveyed by Zacks Investment Research had forecast earnings of $11.62 per share. Regeneron's revenue for the quarter totaled $3.79 billion, meeting analyst expectations.